Moreillon P, Entenza J M, Francioli P, McDevitt D, Foster T J, François P, Vaudaux P
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Infect Immun. 1995 Dec;63(12):4738-43. doi: 10.1128/iai.63.12.4738-4743.1995.
The pathogenic role of staphylococcal coagulase and clumping factor was investigated in the rat model of endocarditis. The coagulase-producing and clumping factor-producing parent strain Staphylococcus aureus Newman and a series of mutants defective in either coagulase, clumping factor, or both were tested for their ability (i) to attach in vitro to either rat fibrinogen or platelet-fibrin clots and (ii) to produce endocarditis in rats with catheter-induced aortic vegetations. In vitro, the clumping factor-defective mutants were up to 100 times less able than the wild type strain to attach to fibrinogen and also significantly less adherent than the parents to platelet-fibrin clots. Coagulase-defective mutants, in contrast, were not altered in their in vitro adherence phenotype. The rate of in vivo infection was inoculum dependent. Clumping factor-defective mutants produced ca. 50% less endocarditis than the parent organisms when injected at inoculum sizes infecting, respectively, 40 and 80% (ID40 and ID80, respectively) of rats with the wild-type strain. This was a trend at the ID40 but was statistically significant at the ID80 (P < 0.05). Coagulase-defective bacteria were not affected in their infectivity. Complementation of a clumping factor-defective mutant with a copy of the wild-type clumping factor gene restored both its in vitro adherence and its in vivo infectivity. These results show that clumping factor plays a specific role in the pathogenesis of S. aureus endocarditis. Nevertheless, the rate of endocarditis with clumping factor-defective mutants increased with larger inocula, indicating the contribution of additional pathogenic determinants in the infective process.
在大鼠心内膜炎模型中研究了葡萄球菌凝固酶和凝聚因子的致病作用。对产凝固酶和产凝聚因子的亲本菌株金黄色葡萄球菌纽曼及其一系列在凝固酶、凝聚因子或两者方面有缺陷的突变体进行了测试,以考察它们(i)在体外与大鼠纤维蛋白原或血小板 - 纤维蛋白凝块结合的能力,以及(ii)在有导管诱导的主动脉赘生物的大鼠中引发心内膜炎的能力。在体外,凝聚因子缺陷型突变体与纤维蛋白原结合的能力比野生型菌株低达100倍,并且与亲本相比,对血小板 - 纤维蛋白凝块的黏附性也显著降低。相比之下,凝固酶缺陷型突变体的体外黏附表型没有改变。体内感染率取决于接种量。当以分别感染40%和80%(分别为ID40和ID80)野生型菌株感染大鼠的接种量注射时,凝聚因子缺陷型突变体引发的心内膜炎比亲本菌株少约50%。在ID40时这是一种趋势,但在ID80时具有统计学意义(P < 0.05)。凝固酶缺陷型细菌的感染性没有受到影响。用野生型凝聚因子基因的一个拷贝对凝聚因子缺陷型突变体进行互补,恢复了其体外黏附能力和体内感染性。这些结果表明凝聚因子在金黄色葡萄球菌心内膜炎的发病机制中起特定作用。然而,凝聚因子缺陷型突变体引发的心内膜炎发生率随着接种量的增加而增加,这表明在感染过程中还有其他致病决定因素起作用。